isoxazoles has been researched along with Streptococcal Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bosselmann, S; Chada, M; Gessner, A; Kandler, M; Nögel, SC; Rascher, W; Schmidt, AM; Schneider, H; Schweer, H; Watzer, B | 1 |
Axon, J; Balasanthiran, A; Darzy, K; Vakilgilani, T | 1 |
2 other study(ies) available for isoxazoles and Streptococcal Infections
Article | Year |
---|---|
Parecoxib does not suppress thromboxane synthesis in newborn piglets with group B streptococcal sepsis.
Topics: Animals; Animals, Newborn; Cyclooxygenase 2 Inhibitors; Dinoprostone; Epoprostenol; Gene Expression Regulation; Hemodynamics; Indomethacin; Inflammation; Isoxazoles; Lung; Platelet Count; Receptors, Prostaglandin E; Sepsis; Streptococcal Infections; Streptococcus agalactiae; Swine; Thromboxanes | 2009 |
A case of severe staphylococcal septicaemia: septic arthritis and a mediastinal abscess following leflunamide therapy for rheumatoid arthritis.
Topics: Abscess; Adrenal Cortex Hormones; Anti-Bacterial Agents; Arthritis, Infectious; Arthritis, Rheumatoid; Bacteremia; Drainage; Female; Follow-Up Studies; Humans; Immunocompromised Host; Immunosuppressive Agents; Isoxazoles; Leflunomide; Middle Aged; Risk Assessment; Severity of Illness Index; Streptococcal Infections; Treatment Outcome | 2010 |